CRYOPORT, INC. Gain (Loss) on Extinguishment of Debt
CRYOPORT, INC. (CYRX) reported Gain (Loss) on Extinguishment of Debt of $18.50 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2026-03-05
- CRYOPORT, INC. gain (loss) on extinguishment of debt for the quarter ending 2024-12-31 was $0.00.
- CRYOPORT, INC. gain (loss) on extinguishment of debt for the quarter ending 2024-09-30 was $17.33M, a 205.09% increase year-over-year.
- CRYOPORT, INC. gain (loss) on extinguishment of debt for the quarter ending 2024-06-30 was $1.18M.
- CRYOPORT, INC. gain (loss) on extinguishment of debt for the quarter ending 2023-12-31 was $0.00.
- CRYOPORT, INC. gain (loss) on extinguishment of debt for fiscal 2024 was $18.50M, a 225.85% increase from fiscal 2023.
- CRYOPORT, INC. gain (loss) on extinguishment of debt for fiscal 2023 was $5.68M.
- CRYOPORT, INC. gain (loss) on extinguishment of debt for fiscal 2021 was -$251.75M.
- CRYOPORT, INC. gain (loss) on extinguishment of debt for fiscal 2020 was $0.00.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $17.33M derived: sum of 2 quarters · filed 2026-03-05 | $18.50M derived: sum of 3 quarters · filed 2026-03-05 | $18.50M 10-K · filed 2026-03-05 |
| 2024-09-30 | $17.33M 10-Q · filed 2025-11-06 | $18.50M derived: sum of 2 quarters · filed 2025-11-06 | $18.50M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $1.18M 10-Q · filed 2025-08-12 | $1.18M 10-Q · filed 2025-08-12 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $5.68M derived: sum of 2 quarters · filed 2026-03-05 | $5.68M 10-K · filed 2026-03-05 | |
| 2023-09-30 | $5.68M 10-Q · filed 2024-11-07 | $5.68M 10-Q · filed 2024-11-07 | ||
| 2021-12-31 | -$251.75M 10-K · filed 2024-03-13 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-02-28 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |